Links:

BOTTOM

Results from PredictProtein for predict_h2275

TOC for file /home/phd/server/work/predict_h2275

1. The following information has been received by the server (TOC)
2. PROSITE motif search (A Bairoch; P Bucher and K Hofmann) (TOC)
3. ProDom domain search (E Sonnhammer; Corpet, Gouzy, D Kahn) (TOC)
4. BLASTP database search (A Karlin and S Altschul) (TOC)
5. MAXHOM alignment header (TOC)
6. MAXHOM alignment (TOC)
7. PHD information about accuracy (TOC)
8. PHD predictions (TOC)
9. GLOBE prediction of globularity (TOC)
10. TOPITS (threading) header (TOC)
11. TOPITS (threading) results in MSF format (TOC)
12. TOPITS (threading) results in HSSP format (TOC)
13. TOPITS (threading) results in STRIP format (TOC)

BEG of results for file /home/phd/server/work/predict_h2275

The following information has been received by the server

reference predict_h2275 (Apr 7, 2000 02:56:27)
PPhdr from: pagomez@cnb.uam.es
PPhdr resp: MAIL
PPhdr orig: HTML
PPhdr want: HTML
PPhdr password(###)
prediction of: - threading             (TOPITS)-
return msf format
ret blastp
ret topits hssp
ret topits strip
ret html
ret html detail
# default: single protein sequence description=CPT1_HUMAN
MAEAHQAVAF QFTVTPDGID LRLSHEALRQ IYLSGLHSWK KKFIRFKNGI ITGVYPASPS
SWLIVVVGVM TTMYAKIDPS LGIIAKINRT LETANCMSSQ TKNVVSGVLF GTGLWVALIV
TMRYSLKVLL SYHGWMFTEH GKMSRATKIW MGMVKIFSGR KPMLYSFQTS LPRLPVPAVK
DTVNRYLQSV RPLMKEEDFK RMTALAQDFA VGLGPRLQWY LKLKSWWATN YVSDWWEEYI
YLRGRGPLMV NSNYYAMDLL YILPTHIQAA RAGNAIHAIL LYRRKLDREE IKPIRLLGST
IPLCSAQWER MFNTSRIPGE ETDTIQHMRD SKHIVVYHRG RYFKVWLYHD GRLLKPREME
QQMQRILDNT SEPQPGEARL AALTAGDRVP WARCRQAYFG RGKNKQSLDA VEKAAFFVTL
DETEEGYRSE DPDTSMDSYA KSLLHGRCYD RWFDKSFTFV VFKNGKMGLN AEHSWADAQI
VAHLWEYVMS IDSLQLGYAE DGHCKGDINP NIPYPTRLQW DIPGECQEVI ETSLNTANLL
ANDVDFHSFP FVAFGKGIIK KCRTSPDTFV QLALQLAHYK DMGKFCLTYE ASMTRLFREG
RTETVRSCTT ESCDFVRAMV DPAQTVEQRL KLFKLASEKH QHMYRLAMTG SGIDRHLFCL
YVVSKYLAVE SPFLKEVLSE PWRLSTSQTP QQQVELFDLE NNPEYVSSGG GFGPVADDGY
GVSYILVGEN LINFHISSKF SCPETDSHRF GRHLKEAMTD IITLFGLSSN SKK

PROSITE motif search (A Bairoch; P Bucher and K Hofmann)

-------------------------------------------------------------
Pattern-ID: ASN_GLYCOSYLATION PS00001 PDOC00001
Pattern-DE: N-glycosylation site
Pattern:    N[^P][ST][^P]
   88       NRTL
   313      NTSR
   369      NTSE

Pattern-ID: GLYCOSAMINOGLYCAN PS00002 PDOC00002
Pattern-DE: Glycosaminoglycan attachment site
Pattern:    SG.G
   708      SGGG

Pattern-ID: CAMP_PHOSPHO_SITE PS00004 PDOC00004
Pattern-DE: cAMP- and cGMP-dependent protein kinase phosphorylation site
Pattern:    [RK]{2}.[ST]
   200      KRMT

Pattern-ID: PKC_PHOSPHO_SITE PS00005 PDOC00005
Pattern-DE: Protein kinase C phosphorylation site
Pattern:    [ST].[RK]
   38       SWK
   121      TMR
   125      SLK
   158      SGR
   189      SVR
   314      TSR
   604      TVR
   637      SEK
   737      SSK
   747      SHR
   771      SKK

Pattern-ID: CK2_PHOSPHO_SITE PS00006 PDOC00006
Pattern-DE: Casein kinase II phosphorylation site
Pattern:    [ST].{2}[DE]
   384      TAGD
   419      TLDE
   434      TSMD
   474      SWAD
   564      TSPD
   651      SGID
   741      SCPE

Pattern-ID: MYRISTYL PS00008 PDOC00008
Pattern-DE: N-myristoylation site
Pattern:    G[^EDRKHPFYW].{2}[STAGCN][^P]
   49       GIITGV
   68       GVMTTM
   107      GVLFGT
   113      GLWVAL
   766      GLSSNS

Pattern-ID: AMIDATION PS00009 PDOC00009
Pattern-DE: Amidation site
Pattern:    .G[RK][RK]
   158      SGRK

Pattern-ID: ACYLTRANSF_C_1 PS00439 PDOC00402
Pattern-DE: Acyltransferases ChoActase / COT / CPT family signature 1
Pattern:    [LI]P.[LVP]P[IVTA]P.[LIVM].[DENQAS][ST][LIVM].{2}[LY]
   171      LPRLPVPAVKDTVNRY

Pattern-ID: ACYLTRANSF_C_2 PS00440 PDOC00402
Pattern-DE: Acyltransferases ChoActase / COT / CPT family signature 2
Pattern:    R[FYW].[DA][KA].{0,1}[LIVMFY].[LIVMFY]{2}.{3}[DNS][GSA].{6}[DE][HS].{3}[DE][GA]
   451      RWFDKSFTFVVFKNGKMGLNAEHSWADA

ProDom domain search (E Sonnhammer; Corpet, Gouzy, D Kahn)

Identities computed with respect to: (query) prot
Colored by: consensus/70% and property

HSP processing: ranked

                                                                            1 [        .         .         .         .         :         .         .         .         .         1         .         .         .         .         :         .         .         .         .         2         .         .         .         .         :    ] 255
  prot           (#) ppOld, default: single ... score      P(N)  N 100.0%     MAEAHQAVAFQFTVTPDGIDLRLSHEALRQIYLSGLHSWKKKFIRFKNGIITGVYPASPSSWLIVVVGVMTTMYAKIDPSLGIIAKINRTLETANCMSSQTKNVVSGVLFGTGLWVALIVTMRYSLKVLLSYHGWMFTEHGKMSRATKIWMGMVKIFSGRKPMLYSFQTSLPRLXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXPLMVNSNYY    
1 PD002032       p99.2 (35) CLAT(6) CACP(4) ...   333  4.9e-175 12  55.6%     ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------PIVVNVNYF    
2 PD014480       p99.2 (5) CPT1(2) CPTM(2) O...   397   1.3e-89  2  78.1%     MAEAHQAVAFQFTVTPDGIDFRLSHEALRHIYLSGIHSWKKRFIRFKNGIIRGVYPGSPTSWLIVVMGTVGSMYCKVDPSLGLIACIQRCLPTANYMTPQTKNLLSGVIFGTGLWVTGIFTFRYTLKLLLSYHGWMFEEHGKMSRATKIWMACVRLLSGRKPMLYSFQT--------------------------------------------------------------------------------------    
3 PD144973       p99.2 (1) O16992_CAEEL // W...    88   0.00099  1  31.3%     -----------------------------------------------------------------------------------------------------------LLIGTVTALTVITVIRCSLIMMLYYNGWLFEEIGKKPSYATTAFFVILGFISKRATFFSYQGILPWL---------------------------------------------------------------------------------    
  consensus/100%                                                              ..............................................................................................................................................................................                                                                        .........    
  consensus/90%                                                               ..............................................................................................................................................................................                                                                        .........    
  consensus/80%                                                               ..............................................................................................................................................................................                                                                        .........    
  consensus/70%                                                               ...........................................................................................................llhGTshhlshIhshRhoLhhhL.YpGWhFpEhGKhsphsphhhhhlhhh.u++shhaSaQs.....                                                                        .........    

--- ------------------------------------------------------------
--- 
--- Again: these results were obtained based on the domain data-
--- base collected by Daniel Kahn and his coworkers in Toulouse.
--- 
--- PLEASE quote: 
---       F Corpet, J Gouzy, D Kahn (1998).  The ProDom database
---       of protein domain families. Nucleic Ac Res 26:323-326.
--- 
--- The general WWW page is on:
----      ---------------------------------------
---       http://www.toulouse.inra.fr/prodom.html
----      ---------------------------------------
--- 
--- For WWW graphic interfaces to PRODOM, in particular for your
--- protein family, follow the following links (each line is ONE
--- single link for your protein!!):
--- 
http://www.toulouse.inra.fr/prodom/cgi-bin/ReqProdomII.pl?id_dom1=PD002032 ==> multiple alignment, consensus, PDB and PROSITE links of domain PD002032
http://www.toulouse.inra.fr/prodom/cgi-bin/ReqProdomII.pl?id_dom2=PD002032 ==> graphical output of all proteins having domain PD002032
http://www.toulouse.inra.fr/prodom/cgi-bin/ReqProdomII.pl?id_dom1=PD014480 ==> multiple alignment, consensus, PDB and PROSITE links of domain PD014480
http://www.toulouse.inra.fr/prodom/cgi-bin/ReqProdomII.pl?id_dom2=PD014480 ==> graphical output of all proteins having domain PD014480
http://www.toulouse.inra.fr/prodom/cgi-bin/ReqProdomII.pl?id_dom1=PD144973 ==> multiple alignment, consensus, PDB and PROSITE links of domain PD144973
http://www.toulouse.inra.fr/prodom/cgi-bin/ReqProdomII.pl?id_dom2=PD144973 ==> graphical output of all proteins having domain PD144973
--- 
--- NOTE: if you want to use the link, make sure the entire line
---       is pasted as URL into your browser!
--- 
--- END of PRODOM
--- ------------------------------------------------------------

BLASTP database search (A Karlin and S Altschul)

Identities computed with respect to: (query) prot
Colored by: consensus/70% and property

HSP processing: ranked


                                                                                      1 [        .         .         .         .         :         .         .         .         .         1         .         .         .         .         :         .         .         .         .         2         .         .         .         .         :         .         .         .         .         3         .         .         .         .         :         .         .         .         .         4         .         .         .         .         :         .         .         .         .         5         .         .         .         .         :         .         .         .         .         6         .         .         .         .         :         .         .         .         .         7         .         .         .         .         :         .         .  ] 773
   prot                    (#) ppOld, default: single ... score      P(N)  N 100.0%     MAEAHQAVAFQFTVTPDGIDLRLSHEALRQIYLSGLHSWKKKFIRFKNGIITGVYPASPSSWLIVVVGVMTTMYAKIDPSLGIIAKINRTLETANCMSSQTKNVVSGVLFGTGLWVALIVTMRYSLKVLLSYHGWMFTEHGKMSRATKIWMGMVKIFSGRKPMLYSFQTSLPRLPVPAVKDTVNRYLQSVRPLMKEEDFKRMTALAQDFAVGLGPRLQWYLKLKSWWATNYVSDWWEEYIYLRGRGPLMVNSNYYAMDLLYILPTHIQAARAGNAIHAILLYRRKLDREEIKPIRLLGSTIPLCSAQWERMFNTSRIPGEETDTIQHMRDSKHIVVYHRGRYFKVWLYHDGRLLKPREMEQQMQRILDNTSEPQPGEARLAALTAGDRVPWARCRQAYFGRGKNKQSLDAVEKAAFFVTLDETEEGYRSEDPDTSMDSYAKSLLHGRCYDRWFDKSFTFVVFKNGKMGLNAEHSWADAQIVAHLWEYVMSIDSLQLGYAEDGHCKGDINPNIPYPTRLQWDIPGECQEVIETSLNTANLLANDVDFHSFPFVAFGKGIIKKCRTSPDTFVQLALQLAHYKDMGKFCLTYEASMTRLFREGRTETVRSCTTESCDFVRAMVDPAQTVEQRLKLFKLASEKHQHMYRLAMTGSGIDRHLFCLYVVSKYLAVESPFLKEVLSEPWRLSTSQTPQQQVELFDLENNPEYVSSGGGFGPVADDGYGVSYILVGENLINFHISSKFSCPETDSHRFGRHLKEAMTDIITLFGLSSNSKK    
 1 swiss|P50416|CPT1_HUMAN CARNITINE O-PALMITOYLTRANSF...  4099       0.0  1 100.0%     MAEAHQAVAFQFTVTPDGIDLRLSHEALRQIYLSGLHSWKKKFIRFKNGIITGVYPASPSSWLIVVVGVMTTMYAKIDPSLGIIAKINRTLETANCMSSQTKNVVSGVLFGTGLWVALIVTMRYSLKVLLSYHGWMFTEHGKMSRATKIWMGMVKIFSGRKPMLYSFQTSLPRLPVPAVKDTVNRYLQSVRPLMKEEDFKRMTALAQDFAVGLGPRLQWYLKLKSWWATNYVSDWWEEYIYLRGRGPLMVNSNYYAMDLLYILPTHIQAARAGNAIHAILLYRRKLDREEIKPIRLLGSTIPLCSAQWERMFNTSRIPGEETDTIQHMRDSKHIVVYHRGRYFKVWLYHDGRLLKPREMEQQMQRILDNTSEPQPGEARLAALTAGDRVPWARCRQAYFGRGKNKQSLDAVEKAAFFVTLDETEEGYRSEDPDTSMDSYAKSLLHGRCYDRWFDKSFTFVVFKNGKMGLNAEHSWADAQIVAHLWEYVMSIDSLQLGYAEDGHCKGDINPNIPYPTRLQWDIPGECQEVIETSLNTANLLANDVDFHSFPFVAFGKGIIKKCRTSPDTFVQLALQLAHYKDMGKFCLTYEASMTRLFREGRTETVRSCTTESCDFVRAMVDPAQTVEQRLKLFKLASEKHQHMYRLAMTGSGIDRHLFCLYVVSKYLAVESPFLKEVLSEPWRLSTSQTPQQQVELFDLENNPEYVSSGGGFGPVADDGYGVSYILVGENLINFHISSKFSCPETDSHRFGRHLKEAMTDIITLFGLSSNSKK    
 2 swiss|P32198|CPT1_RAT   CARNITINE O-PALMITOYLTRANSF...  3653       0.0  1  86.4%     MAEAHQAVAFQFTVTPDGIDLRLSHEALKQICLSGLHSWKKKFIRFKNGIITGVFPANPSSWLIVVVGVISSMHAKVDPSLGMIAKISRTLDTTGRMSSQTKNIVSGVLFGTGLWVAVIMTMRYSLKVLLSYHGWMFAEHGKMSRSTKIWMAMVKVLSGRKPMLYSFQTSLPRLPVPAVKDTVSRYLESVRPLMKEEDFQRMTALAQDFAVNLGPKLQWYLKLKSWWATNYVSDWWEEYIYLRGRGPLMVNSNYYAMEMLYITPTHIQAARAGNTIHAILLYRRTLDREELKPIRLLGSTIPLCSAQWERLFNTSRIPGEETDTIQHIKDSRHIVVYHRGRYFKVWLYHDGRLLRPRELEQQMQQILDDPSEPQPGEAKLAALTAADRVPWAKCRQTYFARGKNKQSLDAVEKAAFFVTLDESEQGYREEDPEASIDSYAKSLLHGRCFDRWFDKSITFVVFKNSKIGINAEHSWADAPIVGHLWEYVMATDVFQLGYSEDGHCKGDTNPNIPKPTRLQWDIPGECQEVIDASLSSASLLANDVDLHSFPFDSFGKGLIKKCRTSPDAFIQLALQLAHYKDMGKFCLTYEASMTRLFREGRTETVRSCTMESCNFVQAMMDPKSTAEQRLKLFKIACEKHQHLYRLAMTGAGIDRHLFCLYVVSKYLAVDSPFLKEVLSEPWRLSTSQTPQQQVELFDFEKNPDYVSCGGGFGPVADDGYGVSYIIVGENFIHFHISSKFSSPETDSHRFGKHLRQAMMDIITLFGLTINSKK    
 3 swiss|P97742|CPT1_MOUSE CARNITINE O-PALMITOYLTRANSF...  3589       0.0  1  85.9%     ---------FQFTVTPDGIDLRLSHEALKQICLSGLHSWKKKFIRFKNGIITGVFPASPSSWLIVVVGVISSMHTKVDPSLGMIAKINRTLDTTGRMSSQTKNIVSGVLFGTGLWVAIIMTMRYSLKVLLSYHGWMFAEHGKMSRSTRIWMAMVKVFSGRKPMLYSFQTSLPRLPVPAVKDTVSRYLESVRPLMKEGDFQRMTALAQDFAVNLGPKLQWYLKLKSWWATNYVSDWWEEYIYLRGRGPIMVNSNYYAMEMLYITPTHIQAARAGNTIHAILLYRRTVDREELKPIRLLGSTIPLCSAQWERLFNTSRIPGEETDTIQHVKDSRHIVVYHRGRYFKVWLYHDGRLLRPRELEQQMQQILDDTSEPQPGEAKLAALTAADRVPWAKCRQTCFARGKNKQSLDAVEKAAFFVTLDESEQGYREEDPEASIDSYAKSLLHGRCFDRWFDKSITFVVFKNSKIGINAEHSWADAPIVGHLWEYVMATDVFQLGYSEDGHCKGDKNPNIPKPTRLQWDIPGECQEVIETSLSSASFLANDVDLHSFPFDTFGKGLIKKCRTSPDAFIQLALQLAHYKDMGKFCLTYEASMTRLFREGRTETVRSCTTESCNFVLAMMDPTTTAEQRLKLFKIACEKHQHLYRLAMTGAGIDRHLFCLYVVSKYLAVDSPFLKEVLSEPWRLSTSQTPQQQVELFDFEKYPDYVSCGGGFGPVADDGYGVSYIIVGENFTHFHISSKFSSPETDSHRFGKHLRQAMMAIITLFGLTANSKK    
 4 swiss|Q92523|CPTM_HUMAN CARNITINE O-PALMITOYLTRANSF...  1270  4.5e-174  1  39.1%     MAEAHQAVAFQFTVTPDGVDFRLSREALKHVYLSGINSWKKRLIRIKNGILRGVYPGSPTSWLVVIMATVGSSFCNVDISLGLVSCIQRCLPQGCGPYQTPQTRALLSMAIFSTGVWVTGIFFFRQTLKLLLCYHGWMFEMHGKTSNLTRIWAMCIRLLSSRHPMLYSFQTSLPKLPVPRVSATIQRYLESVRPLLDDEEYYRMELLAKEFQDKTAPRLQKYLVLKSWWASNYVSDWWEEYIYLRGRSPLMVNSNYYVMDLVLIKNTDVQAARLGNIIHAMIMYRRKLDREEIKPVMALGIVPMCSYQMERMFNTTRIPGKDTDVLQHLSDSRHVAVYHKGRFFKLWLYEGARLLKPQDLEMQFQRILDDPSPPQPGEEKLAALTAGGRVEWAQARQAFFSSGKNKAALEAIERAAFFVALDEESYSYDPEDEASLSLYGKALLHGNCYNRWFDKSFTLISFKNGQLGLNAEHAWADAPIIGHLWEFVLGTDSFHLGYTETGHCLGKPNPALAPPTRLQWDIPKQCQAVIESSYQVAKALADDVELYCFQFLPFGKGLIKKCRTSPDAFVQIALQLAHFRDRGKFCLTYEASMTRMFREGRTETVRSCTSESTAFVQAMMEGSHTKADLRDLFQKAAKKHQNMYRLAMTGAGIDRHLFCLYLVSKYLGVSSPFLAEVLSEPWRLSTSQIPQSQIRMFDPEQHPNHLGAGGGFGPVADDGYGVSYMIAGENTIFFHISSKFSSSETNAQRFGNHIRKALLDIADLF--------    
 5 swiss|Q63704|CPTM_RAT   CARNITINE O-PALMITOYLTRANSF...  1246  1.0e-170  1  38.4%     MAEAHQAVAFQFTVTPDGVDFRLSREALRHIYLSGINSWKKRLIRIKNGILRGVYPGSPTSWLVVVMATVGSNYCKVDISMGLVHCIQRCLPTRYGSYGTPQTETLLSMVIFSTGVWATGIFLFRQTLKLLLSYHGWMFEMHSKTSHATKIWAICVRLLSSRRPMLYSFQTSLPKLPVPSVPATIHRYLDSVRPLLDDEAYFRMESLAKEFQDKIAPRLQKYLVLKSWWATNYVSDWWEEYVYLRGRSPIMVNSNYYAMDFVLIKNTSQQAARLGNTVHAMIMYRRKLDREEIKPVMALGMVPMCSYQMERMFNTTRIPGKETDLLQHLSESRHVAVYHKGRFFKVWLYEGSCLLKPRDLEMQFQRILDDTSPPQPGEEKLAALTAGGRVEWAEARQKFFSSGKNKMSLDTIERAAFFVALDEDSHCYNPDDEASLSLYGKSLLHGNCYNRWFDKSFTLISCKNGQLGLNTEHSWADAPIIGHLWEFVLATDTFHLGYTETGHCVGEPNTKLPPPQRMQWDIPEQCQTAIENSYQVAKALADDVELYCFQFLPFGKGLIKKCRTSPDAFVQIALQLAHFRDKGKFCLTYEASMTRMFREGRTETVRSCTSESTAFVRAMMTGSHKKQDLQDLFRKASEKHQNMYRLAMTGAGIDRHLFCLYIVSKYLGVRSPFLDEVLSEPWSLSTSQIPQFQICMFDPKQYPNHLGAGGGFGPVADHGYGVSYMIAGENTMFFHVSSKLSSSETNALRFGNHIRQALLDIADLFKIS-----    
 6 swiss|P52826|CACP_COLLI CARNITINE O-ACETYLTRANSFERA...   288   1.9e-79  9  26.4%     -----------------------------------------------------------------------------------------------------------------------------------------------------------------------QEALPHLPVPPLQQTLDRYLLALQPIISEEELNHTQELVAEF--GVGERLQKGLERRAKKTDNWLSDWWLKTAYLEYRLPVVVHSS------------------------------------------------PLCMNQYYQILSSCRIPGPKRDSIVNYAKGKHITVVHNFQFFELDVYN------------------------QTNKEPVGILTTNHRNSWAKAYNNLLKDKTNKESVRTIEKSICTICLD----------------------------NRWFDKTLQFIIAEDGSCGLVYEHAPAEGPPIVALLDHIV----------------------LPMPKKLRFNITPEIKSDIEKAKQNLNIMVEDLDVIVLVFHQFGKNYPKSEKISPDAFIQLALQLAYYRMYGHSCATYESASLRMFRLGRTDTIRSTSIESHKFVQSMDSPDKSDQEKADLLRRATQAHKEYTNMAIQGNAIDRHLLGL---------------------------------------------------FGPVVPDGYGICYNPMGEHIINFAISAFNSCADTNAARMAHYLEKALLDMRSLLQSAPKSK-    
 7 swiss|P43155|CACP_HUMAN CARNITINE O-ACETYLTRANSFERA...   267   1.8e-76  9  26.0%     -----------------------------------------------------------------------------------------------------------------------------------------------------------------------QDALPRLPVPPLQQSLDHYLKALQPIVSEEEWAHTKQLVDEFQASGGERLQKGLGRRARKTENWLSEWWLKTAYLQYRQPVVIYSS------------------------------------------------PLCMNQYYQILSSCRVPGPKQDTVSNFSKTKHITVVHNYQFFELDVYH---------------------SSLQTNKEPVGILTSNHRNSWAKAYNTLIKDKVNRDSVRSIQKSIFTVCLDAT--------------------------NRWFDKTLQFIVAEDGSCGLVYEHAAAEGFPIVTLLDYVI----------------------LPMPKKLRFNITPEIKSDIEKAKQNLSIMIQDLDITVMVFHHFGKDFPKSEKLSPDAFIQMALQLAYYRIYGQACATYESASLRMFHLGRTDTIRSASMDSLTFVKAMDDSSVTEHQKVELLRKAVQAHRGYTDRAIRGEAFGRHLLGL---------------------------------------------------FGPVVPDGYGVCY-------INFSLSAYNSCAETNAARLAHYLEKALLDMRAL---------    
 8 swiss|O19094|OCTC_BOVIN PEROXISOMAL CARNITINE OCTAN...   262   9.6e-72  8  35.0%     --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------YLRVQGVMVPMVHNGYGFFY-------------------------------------------------    
 9 swiss|P13222|CLAT_PIG   CHOLINE O-ACETYLTRANSFERASE...   230   3.0e-70  9  26.9%     -----------------------------------------------------------------------------------------------------------------------------------------------------------------------EPGLPKLPVPPLQQTLATYLRCMQHLVPEEQFRRSQAIVQQF--GLGETLQQKLLERQEQTANWVSEYWLNDMYLNNRLALPVNSS------------------------------------------------PLCMKQYYGLFSSYRLPGHTQDTLVAMPEPEHVIVACCNQFFVLDVVINFRRLSEGDLFTQLRKIVRMASNEDERLPPIGLLTSDGRSEWAEARTVLVKDSTNRDSLDMIERCICLVCLD----------------------------NRWYDKSLQFVVGRDGTCGVVCEHSPFDGIVLVQCTEHLL---------------RADSVSELPAPRRLRWKCSPEIQGLLASSAEKLQQIVKNLDFTVYKFDDYGKTFIKQQKCSPDAFIQVALQLAFYRLHGRLVPTYESASIRRFHEGRVDNIRSATPEALHFVKAITDHASAMPDSEKLLLLAIRAQTQYTVMAITGMAIDNHLLGLRELAREVCKELP---------------------------------------YGPVVPNGYGACY-------ILFCISSFHGCKETSSTKFAKAVEESFIEMKGLCSLSQS---    
10 swiss|Q03059|CLAT_MOUSE CHOLINE O-ACETYLTRANSFERASE...   216   1.0e-68  9  27.2%     --------------------------------------------------------------------------------------------------------------------------------------------------------------------------LPKLPVPPLQQTLATYLQCMQHLVPEEQFRKSQAIVKRF--GLGETLQEKLLERQEKTANWVSEYWLNDMYLNNRLALPVNSS------------------------------------------------PLCMKQYYRLFSSYRLPGHTQDTLVAMPEPEHVIVACCNQFFVLDVVINFRRLSEGDLFTQLRKIVKMASNEDERLPPIGLLTSDGRSEWAKARTVLLKDSTNRDSLDMIERCICLVCLDGPGTGDLSD-------------------NRWYDKSLQFVVGRDGTCGVVCEHSPFDGIVLVQCTEHLL----------------------LPAPRRLRWKCSPETQGHLASSAEKLQRIVKNLDFIVYKFDNYGKTFIKKQKCSPDGFIQVALQLAYYRLYQRLVPTYESASIRRFQEGRVDNIRSATPEALAFVQAMTDHKAAVLASEKLLQRAIQAQTEYTVMAITGMAIDNHLLALRELARDLCKEPP---------------------------------------YGPVVPNGYGACY-------ITFCISSFHGCKETSSVEFAEAVGASLVDM------------    
11 swiss|P28329|CLAT_HUMAN CHOLINE O-ACETYLTRANSFERASE...   220   1.4e-68  9  27.4%     ---------------------------------------------------------------------------------------------------------------------------------------------------------------------SEESGLPKLPVPPLQQTLATYLQCMRHLVSEEQFRKSQAIVQQF--GLGETLQQKLLERQEKTANWVSEYWLNDMYLNNRLALPVNSS------------------------------------------------PLCMKQYYGLFSSYRLPGHTQDTL--MPEPEHVIVACCNQFFVLDVVINFRRLSEGDLFTQLRKIVKMASNEDERLPPIGLLTSDGRSEWAEARTVLVKDSTNRDSLDMIERCICLVCLD----------------------------NRWYDKSLQFVVGRDATCGVVCEHSPFDGIVLVQCTEHLL---------------RADSVSELPAPRRLRWKCSPEIQGHLASSAEKLQRIVKNLDFIVYKFDNYGKTFIKKQKCSPDAFIQVALQLAFYRLHRRLVPTYESASIRRFQEGRVDNIRSATPEALAFVRAVTDHKAAVPASEKLLLLAIRAQTAYTVMAITGMAIDNHLLALRELARAMCKELP---------------------------------------YGPVVPNGYGACY-------ILFCISSFHSCKETSSSKFAKAVEESLIDMRDLCSL------    
12 swiss|P11466|OCTC_RAT   PEROXISOMAL CARNITINE OCTAN...   263   1.1e-67  7  26.2%     --------------------------------------------------------------------------------------------------------------------------------------------------------------------FQYQDSLPPLPVPSLEESLKKYLESVKPFANEDEYKKTEEIVQKFQDGVGKTLHQKLLERAKGKRNWLEEWWLNVAYLDVRIPSQLNVNF-----------------------------------------------PLDMNQFRMLFSTCKVPGITRDSIMN-----HIAVLCRGRAFVFDVLHDGCLITPPELLRQLTYI-------EPVGPSIAALTSEERTRWAKAREYLIGLDPENLTLLEKIQSSLFV------------------------LLGGDPAVRWGDKSYNLISFANGIFGCSCDHAPYDAMLMVNIAHYV----------------------DIPLPEELAFTVDEKILNDVYQAKAQHLKAASDLQIAASTFTSFGKKLTKKEALHPDTFIQLALQLAYYRLHGRPGCCYETAMTRYFYHGRTETVRSCTVEAVRWCQSMQDPSASLLERQQKMLDAFAKHNKMMRDCSHGKGFDRHLLGLLLIAKEEGLPVPELFE------------------------------------------------------------SSWRSCLETDAEKLVEMIFHAFHDMIHL---------    
13 swiss|P47934|CACP_MOUSE CARNITINE O-ACETYLTRANSFERA...   265   1.9e-67  8  23.6%     -----------------------------------------------------------------------------------------------------------------------------------------------------------------------QDALPRLPVPPLQQSLDYYLKALQPIVSEEEWAHTKQLVDEFQTSGGERLQKGLERRAKKMENWLSEWWLKTAYLQ----------------------------------------------------------PLCMNQYYQILSSCREPGPKQDSVVNFLKSK--------------------------------------SSLQSNKEPVGILTSNHRNTWAKAYNNLIKDKVNRESVNSIQKSIFTVCLDK---------------------------NRWFDKTLQFIVAEDGSCGMVYEHAAAEGPPIVALVDHVM----------------------LPMPKKLRFNITPEIKNDIEKAKQNLSIMIQDLDIMMLTFHHFGKDFPKSEKLSPDAFIQVALQLAYYRIYGQACATYESASLRMFHLGRTDTIRSASIDSLAFVKGMGDSTVPEQQKVELLRKAVQAHRAYTDRAIRGEAFDRHLLGL---------------------------------------------------FGPVVPDGYGICY-------INLSVSAYNSCAETNAARMAHYLEKALLDMRTL---------    
14 swiss|P32738|CLAT_RAT   CHOLINE O-ACETYLTRANSFERASE...   211   8.2e-61  8  25.6%     -----------------------------------------------------------------------------------------------------------------------------------------------------------------------ELDLPKLPVPPLQQTLATYLQCMQHLVPEEQFRKSQAIVKRF--GLGETLQEKLLERQEKTANWVSEYWLNDMYLNNRLALPVNSS------------------------------------------------PLCMKQYYRLFSSYRLPGHTQDTLVAMPEPEHVIVACCNQFFVLDVVINFRRLSEGDLFTQLRKIVKMASNEDERLPPIGLLTSDGRSEWAKARTVLLKDSTNRDSLDMIERCICLVCLDGPGTGELSD-------------------NRWYDKSLQFVVGRDGTCGVVCEHSPFDGIVLVQCTEHLL---------------RADSVSELPAPRRLRLKCSPETQGHLASSAEKLQRIVKNLDFIVYKFDNYGKTFIKKQKYSPDGFIQVALQLAYYRLYQRLVPTYESASIRRFQEGRVDNIRSATPEALAFVQAMTDHKAAMPASEKLQLLQTAMQAHKQYTVMAITGM----------------------------------------------------------YGPVVPNGNGACY-------ITFCISSFHSCKETSSVEFAEAVGASLVDM------------    
15 swiss|Q00614|CACP_CANTR CARNITINE O-ACETYLTRANSFERA...   239   5.9e-60  8  23.6%     -------------------------------------------------------------------------------------------------------------------------------------------------------------SHAKGDLFKYQSQLPKLPVPTLEETASKYLKTVEPFLNQEQLESTKAKVAEF--GAGEALQARLNNFAADKDNWLAEFWDDYAYMSYRDPVVPYVSYF----------------------------------------------PFCMNAFKYMFNNSRVPAEGSDITQH--ENQFFVVIYKNNFYKVPTHKNGQRLTKGEIYSYLQEIKNDATPKGLGLGALTSL---------------------------------------------------TIEEKSKNCWHGDGQNRFFDKPLEFFVSANGNSGFLGEHSRMDA------------------------------------------------------------------DEEIFQHYGYGKGLIKKFKVSPDAYVQLLMQLAYFKYTGKIRPTYESAATRKFLKGRTETGRTVSNESKKFVETWSDPNASSADKVATFQAAAKQHVAYLSAAADGKGVDRHLFGL------------------SQTWYISSSQVPSE------------------GWSQVIDDGFGLAYLI-----------------------------------------------    
16 swiss|P18886|CPT2_RAT   CARNITINE O-PALMITOYLTRANSF...   137   5.5e-55  9  23.5%     ----------------------------------------------------------------------------------------------------------------------------------------------------------------------YQDSLPRLPIPKLEDTMKRYLNAQKPLLDDSQFRRTEALCKNFETGVGKELHAHL---------------------------------------------------------------------------LVNAYPLDMSQYFRLFNSTRIPRPNRDELFTDTKARHLLVLRKGHFY---LDQDGNIVNPLEIQAHLKYILSDSS-----EFPVAYLTSENRDVWAELRQ-------NEETLKKVDSAVFCLCLDD-------------------TMLHGDGTNRWFDKSFNLIVAEDGTAAVHFEHSWGDGVAVLRFFNEV-----------------------------LSFNLSGALKAGITAAKEKFDTTVKTLSIDSIQFQRGGKEFLKKKQLSPDAVAQLAFQMAFLRQYGQTVATYESCSTAAFKHGRTETIR------------------------------SKYHGQLTKEAAMGQGFDRHLYALRYLATARGLNLPEL-----------------------------------GGFAPVVPDGFGIAY-------------------------------------------------    
17 swiss|P52825|CPT2_MOUSE CARNITINE O-PALMITOYLTRANSF...   134   5.5e-55  9  23.7%     ----------------------------------------------------------------------------------------------------------------------------------------------------------------------YQDSLPRLPIPKLEDTMKRYLSAQKPLLNDSQFRKTEVLCKDFENGIGKELHAHL---------------------------------------------------------------------------LVNAYPLDMSQYFRLFNSTRIPKPSRDELFTDTKARHLLVLRKGHFY---LDQDGNIVNPSEIQAHLKYILSDSS-----EFPLAYLTSENRDVWAELRQKLIHGGGNEETLRKVDSAVFCLCLDD-------------------TMLHGDGTNRWFDKSFNLIVAKDGTAAVHFEHAWGDGVAVLRFFNEV------------------------------------------------------------------GKEFLKKKKLSPDAVAQLAFQMAFLRQYGQTVATYESCSTAAFKHGRTETI-SIFTKRCSEAFVREPSKHSVGELQHMMAECSKYHGQLTKEAAMGQGFDRHLFALRYLAAARGVTLPEL-----------------------------------GGFAPVVPDGFGIAY-------------------------------------------------    
18 swiss|P23786|CPT2_HUMAN CARNITINE O-PALMITOYLTRANSF...   122   2.3e-53  9  22.0%     ----------------------------------------------------------------------------------------------------------------------------------------------------------------------YQDSLPRLPIPKLEDTIRRYLSAQKPLLNDGQFRKTEQFCKSFENGIGKEL-------------------------------------------------------------------------------LVNAYPLDMSQYFRLFNSTRLPKPSRDELFTDDKARHLLVLRKGNFY---LDQDGNIVSPSEIQAHLKYILSDSS-----EFPLAYLTSENRDIWAELRQKLMSSGNEEESLRKVDSAVFCLCLDD-------------------NMLHGDGTNRWFDKSFNLIIAKDGSTAVHFEHSWGDGVAVLRFFNEV------------------------------------------------------------------GKEFLKKQKLSPDAVAQLAFQMAFLRQYGQTVATYESCSTAAFKHGRTETIR------------------------------SKYHGQLTKEAAMGQGFDRHLFAL-------------------------------------------------GGFAPVVSDGFGVGY-------------------------------------------------    
19 swiss|P32756|CLAT_CAEEL CHOLINE O-ACETYLTRANSFERASE...   251   2.3e-51  8  22.5%     ----------------------------------------------------------------------------------------------------------------------------------------------------------------------YETALPKPPVPSLEATLDRYLE-----------------------------------------NWATKFWLPEMYMRVRMPTPVNSN-----------------------------------------------LQMCMEQYDRVLSCYREPGVGEDT------NEHVLVMCRNQTFLLHSRINGALVSYADVEYQLAQIEEISKINQNNTANIGASGVGPRDNAALFWQDMLTVEQNSKSYEWVKSALFVVCLD----------------------------NRWYDATIQLVVSSSGVNGLCIEHSTAEGIVIINMAE---------------------------HPKSLTWHFSENSRNILKKQAEVFDELANELELEVLIFNEFGKDSIKNWRVSPDGFIQLIMQLAHYKTHGHLVSTYESASVRRFGAGRVDNIRANTQEALEWVTAMASKKESKERKLELFKKAVLKQVKVTLENISGYGVDNHLCALFCLAR----------------------------------------------YGAVVRDGYGCPYNIQPDRVI--------SDPRTDLQHFKKSLAGAMRDV------------    
20 swiss|P80235|CACM_YEAST PUTATIVE MITOCHONDRIAL CARN...   183   1.1e-50 11  24.8%     -------------------------------------------------------------------------------------------------------------------------------------------------------------------------NLKRLPIPPLQDTLNRYLARVETLQDERQNRR---------------------------------WYDAYLLYDATVVLNVNPYFQLQDDPTIKDTPETAAQGPYGAHTVQVRR------------------PLSMDQYERLFGSSRIPGEPSCHLQTDATSHHVVAMYRGQFY------------PEQLEWNLYSIIMDAESAGSGSAPFGVFTTESRRVWSNIRDYLF----NWRNLKLIDSALFVVCLDD-----------------------GTCLNRWYDK----IVTKNGKAGINFEHTGVDGHTVLRL---------------------------ITIPRKLEWRTDNFLQSSLHFAETRISDLISQYEFVNLDFSNYGASHIK--KCSPDAFVQQVFQVAYFALYGRFETVYEPAMTKAFQNGRTEAIRSVTGQSKLFVKSLLDQDASDATKIQLLHDACTAHSQITRECSQGLGQDRHLYALY-------------------------------------------------GFGPVTANGFGIGYII-----------------------------------------------    
21 swiss|P32796|CACP_YEAST CARNITINE O-ACETYLTRANSFERA...   234   6.5e-46  6  21.2%     --------------------------------------------------------------------------------------------------------------------------------------------------------------------FAKQQDLPSLPVPELKSTLDKYLQTIRPFCNDETFERQQLLCKDFSEHMGPILQDRLKEYANDKRNWMAKFWDEQSYLQYNDPIVPYVSYF---------------------------------------------MPFCMNSFSLMFNTSRLPGKPEDIFYSVYENNFVTIAYKGKFYKL-----------------------------------------------------------------------------------------TLEEKSRNCWHGDGINRFYDKSLQFLVTGNGSSGFLAEHSKMDGTPTLFLNNYVCQQLNKLDVDDFMRKVITPSSTVAMKPMELPFIITPKIHKAIESAQLQFKETIGEHDLRVWHYNKYGKTFIKRHGMSPDAFIQQVIQLAVFKYLKRQLPTYEAASTRKYFKGRTETGRSVSTASLEFVSKWQNGDVPIAEKIQALKHSAKEHSTYLKNAANGNGVDRHFFGL------------------------------------------------GYGWSQVNDNGFGLAYMLNNE--------------------------------------------    
22 swiss|P07668|CLAT_DROME CHOLINE O-ACETYLTRANSFERASE...   118   4.7e-35  7  16.8%     --------------------------------------------------------------------------------------------------------------------------------------------------------------------FGFPDTLPKVPVPALDETMADYIRALEPITTPAQLERTKELIRQFSAPQG---------------------------------------------------------------------------------------PLCMAQYYRLLGSCRRPGVKQDS-----DRHVVVICRNQMYCVVLQASDRGKLSESEIASQILYVLSDAPCLPAKPVPVGLLTAEPRSTWARDREMLQEDERNQRNLELIETAQVVLCLDEPLAG-----------------------NRWFDKTMQLIICTDGTWGLCYEHSCSEGIAVVQLLEKI----------------------HLPPPERLEWHVGPQLQLRFAQASKSVDKCIDDLDFYVYRYQSYGKTFIKSCQVSPDVYIQLA-----------------------------------------------------------------------------------------------------------------------------------------GYGPVTPRGYGCSY-------IVFCVSAFYSCEDTSASRYAKSLQDSL---------------    
23 swiss|P75448|YC00_MYCPN PUTATIVE ACETYLTRANSFERASE ...    77   1.1e-23  7  14.8%     -------------------------------------------------------------------------------------------------------------------------------------------------------------------LFINQDNIPNLPTEAPQVYLARFLEWVEPLVSKVKFVKAQAAVQDY-------------------SSWLANWWVQYAYLTSTGPVSPEVN-----------------------------------------------------------------------------------------------------------------------------------------------------QNPEMLLDIYNSAFIVNLDNVE------------------------FNRWHAKGIQLVITKNAQLVILADHTSFDGSSVATL----------------------------------------------------------------------------------EAFIHLCYQIAQYQTNKKLQNTYVAVDMRQYFRGRTECLRPLSKQSVAFVK---DPKGTLKQFRKYYPAIESLHFEKTRLAQKGSGVNRHLLGAYL-------------------------------------------------FDPVEPNGIGIAYAIDDTN-------------------------------------------    
24 swiss|P40017|YEL4_YEAST HYPOTHETICAL 103.3 KD PROTE...   119   1.8e-23  7  15.1%     -------------------------------------------------------------------------------------------------------------------------------------------------------GSTIVSSDKSGRTFKHEEELPKLPLPKLCDTLQRLKESLEPL---------------------------------------------------------------------LPNITQADRSAVLVHSAARFISALKQDLLPPDINATNGKPLSMAPFLNLFGTTRSP-----TIKRHPDSKHILIISRGQYY----------------------------------------------------------------LHRIDSALFVLVLDESQEETTNDGDDTA----------GSCVSRWYDK------------------------------------------------------------------------------------------------IPLGRRSAQRLGVKPDSMVQVALQIAHYALYGRMVFGLEPVSTRGFKNSRSSFINIQSQALLELCQLFISSSIDGTDKLDKFIQTCETHNNMVKHAKSGVGYEKHFNALKYLFKF--------------------------------------------GITPAVPHGFGIGYII-----------------------------------------------    
25 swiss|Q91611|DHH2_XENLA DESERT HEDGEHOG PROTEIN PRE...    71      0.21  2   3.8%     ---------------------------LIQIYVNGTQVQSSKVVRVSVDEQTGVYAPMTEHGTLLVDGVLTSCYATVE------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------TSDGVHWYCHILYVLAKYV----------------------------------------------------------------------------------------------------------    
26 swiss|P49891|SUOT_MOUSE ESTROGEN SULFOTRANSFERASE, ...    54      0.26  3   3.9%     ------------------------------------------FLARPDDLVIATYPKSGTTWISEVV----------------------------------------------------------------------------------------------------------------KDVAVSYYYFLLMITSYPNPKSFSEFVEKFMQGQVPYGSWYDHVKAWW-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------PEALRERFDEHYKQQMKDCTVKF--------    
27 swiss|P49889|SUO3_RAT   ESTROGEN SULFOTRANSFERASE, ...    58      0.63  3   3.9%     ------------------------------------------FLARPDDLLIVTYPKSGSTWISEIVDMI-------------------------------------------------------------------------------------------------------------KDVVVSYYYFFLIMKSYPNPKSFSEFVEKFMEGQVPYGSWYDHVKSWW-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------PEALRERFEEHYQQQMKD-------------    
28 swiss|P30860|ARTJ_ECOLI ARGININE-BINDING PERIPLASMI...    59      0.64  2  29.6%     -------------------------------------SYQNAFIDLKNGRIDGVF--------------------RIDGVFGDTAVVNEWLKTNPQLGVATEKVTDPQYFGTGLGIAV-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------    
29 swiss|Q91610|DHH1_XENLA DESERT HEDGEHOG PROTEIN PRE...    70      0.78  2   3.6%     ---------------------------LVQIYVNGTQVQSSKVVRVSLEEQTGVYAPMTEHGTLLVDGVLTSCYATVE---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------GVHWYCHILYVLAKYV----------------------------------------------------------------------------------------------------------    
30 swiss|P52845|SUO2_RAT   ESTROGEN SULFOTRANSFERASE, ...    58      0.96  3   3.8%     -------------------------------------------------LLVVTYPKSGSTWIGEIVDMI-------------------------------------------------------------------------------------------------------------KDVVVSYYYFFLIMKSYPNPKSFSEFVEKFMEGQVPYGSWYDHVKSWW-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------PEALRERFEEHYQQQMKD-------------    
31 swiss|Q60258|YZ34_METJA HYPOTHETICAL PROTEIN MJECL34.     56      0.97  2  28.2%     -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------KKLYVYYDERYPYSWIPHNVAKHISKELEKYDFEVLDNPDNPTSNSLLRRFLNAGQIIVWMGDSPQYVGRADDNQKLN----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------    
32 swiss|P19340|SXLM_DROME SEX-LETHAL PROTEIN, MALE-SP...    38      0.98  2  23.2%     ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------NNPGSNNNNGGYPP-------------------------FHSPERSSHHYHRKAKD-----------------    
33 swiss|P50503|HIP_RAT    HSC70-INTERACTING PROTEIN.        64     0.998  2  24.4%     -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IKERIERVKKAREEHEKAQR--------------------------PGLNEILSDPEVLAAMQDPEVMVAFQDVAQNPSNMS------------------------------------------------------------------    
34 swiss|P50502|HIP_HUMAN  HSC70-INTERACTING PROTEIN (...    63     0.998  2  24.4%     -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------IKERIERVKKAREEHERAQR--------------------------PGLNEILSDPEVLAAMQDPEVMVAFQDVAQNPANMS------------------------------------------------------------------    
35 swiss|P52844|SUO1_RAT   ESTROGEN SULFOTRANSFERASE, ...    58     0.998  2  11.4%     ------------------------------------------FLARPDDLLIVTYPKSGSTWISEIVDMI-------------------------------------------------------------------------------------------------------------KDVVVSYYYFFLIMKSYPNPKSFSEFVEKFMEGQVPYGSWYDHVKSWW------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------    
36 swiss|P87140|COPG_SCHPO PROBABLE COATOMER GAMMA SUB...    56     0.998  3  21.9%     ------------------------------------------------------------------------------------------------------------------------------------------EHFQEKQATELFFGITKLFQHKDPSLRQF---------PVAKDIVSRWNNEVQDAVTSHNVGRKVASSPFFTSTLG-------------------------------------SQYHALGLLYRIRRH---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------    
37 swiss|Q28943|DPYD_PIG   DIHYDROPYRIMIDINE DEHYDROGE...    57    0.9995  2  14.3%     --------------------------------------------------------------------VQIPFFAKLTPNVTDIVSIARAAKEGGADGVTATNTVSGLM-------------------------------------------------------------IPKKPIPAIKDVIGKALQYLGTFGELSNIEQVVAVIDE-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------    
38 swiss|P29782|STRE_STRGR DTDP-GLUCOSE 4,6-DEHYDRATAS...    63    0.9996  1  50.0%     -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------APAVDLADGLAATVAWYHKHRSWW------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------    
39 swiss|P40776|TSX_SALTY  NUCLEOSIDE-SPECIFIC CHANNEL...    52    0.9997  2   7.5%     --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------YLSDWWHQSVNVVG-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------DDPNRTSNSIASSHILALNYDHWHYSVVARYFHNGGQWQNGAKLNWGDGDFSA---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------    
40 swiss|P40823|ORGA_SALTY OXYGEN-REGULATED INVASION P...    50   0.99995  4   6.4%     ---------------------KLRADLARQGALLGLPDWAQAFLAMHQGTSLSVCNKAPNHRFLLSVG----------------------------------------------------------------------------------------------LLLALQYCLKNIPIPSPLSPVEGILIKRKTLERYFSIERLEQQAHQRA----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------RMYAYQEGYEQGMIDALQQVAAYLTDNQT-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ELPQDCRTISDNAINALIDEWKTKTQ-------------------------------------------------------------------------------------------------------------------------------------------------    
   consensus/100%                                                                       .....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................    
   consensus/90%                                                                        ....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................     
   consensus/80%                                                                                                   ...................................................                                                                               ..................................................................................................       ....                              ......................................................................................................................................    .......................................................               ............................................................................................................................................................................  ..............        ....... ...................... ..................................            
   consensus/70%                                                                                                                  .........................                                                                                                 ...............p.sh..hh.....h....p.......................................................                                                ..........................................................................................................................                   ...............................................                      ............................................................................................................................................................    .                                      ................     .................................             

MAXHOM alignment header

--- ------------------------------------------------------------
--- MAXHOM multiple sequence alignment
--- ------------------------------------------------------------
--- 
--- MAXHOM ALIGNMENT HEADER: ABBREVIATIONS FOR SUMMARY
--- ID           : identifier of aligned (homologous) protein
--- STRID        : PDB identifier (only for known structures)
--- PIDE         : percentage of pairwise sequence identity
--- WSIM         : percentage of weighted similarity
--- LALI         : number of residues aligned
--- NGAP         : number of insertions and deletions (indels)
--- LGAP         : number of residues in all indels
--- LSEQ2        : length of aligned sequence
--- ACCNUM       : SwissProt accession number
--- NAME         : one-line description of aligned protein
--- 
--- MAXHOM ALIGNMENT HEADER: SUMMARY
ID         STRID  IDE WSIM LALI NGAP LGAP LEN2 ACCNUM NAME                     
cpt1_human        100  100  773    0    0  773 P50416 (EC 2.3.1.21) (CPT I) (CP
cpt1_rat           86   92  773    0    0  773 P32198 (EC 2.3.1.21) (CPT I) (CP
cpt1_mouse         86   91  764    0    0  764 P97742 (EC 2.3.1.21) (CPT I) (CP
cptm_human         63   74  765    3    4  772 Q92523 PROTEIN).                
cptm_rat           63   74  766    3    4  772 Q63704 LIKE PROTEIN).           
clat_mouse         33   45  570   12   45  640 Q03059 ACETYLASE).              
clat_pig           33   45  579   12   45  640 P13222 ACETYLASE).              
clat_rat           32   44  573   12   45  639 P32738 ACETYLASE).              
cacp_human         32   43  601   14   47  624 P43155 (CAT) (FRAGMENT).        
octc_rat           31   40  578   11   45  612 P11466 PEROXISOMAL CARNITINE OCT
cacp_colli         31   43  609   12   45  627 P52826 ACETYLASE) (CAT).        
clat_human         30   39  689   16   88  748 P28329 ACETYLASE).              
cacp_mouse         30   41  601   13   48  627 P47934 (CAT).                   
octc_bovin         28   40  587   10   45  612 O19094 PEROXISOMAL CARNITINE OCT
cpt2_human         28   32  613   16   71  658 P23786 (EC 2.3.1.21) (CPT II).  
cacp_cantr         28   34  615   13   51  627 Q00614 ACETYLASE).              
clat_caeel         28   34  587   13   45  627 P32756 ACETYLASE).              
cpt2_mouse         28   32  608   15   71  658 P52825 (EC 2.3.1.21) (CPT II).  
cpt2_rat           28   32  607   14   70  658 P18886 (EC 2.3.1.21) (CPT II).  
cacm_yeast         28   31  589   15   75  688 P80235 PUTATIVE MITOCHONDRIAL CA
cacp_yeast         26   33  638   11   43  670 P32796 ACETYLASE).              
--- 
--- MAXHOM ALIGNMENT: IN MSF FORMAT

--- 
--- Version of database searched for alignment:
--- SWISS-PROT release 38.0 (7/99) with 80000 proteins
--- 

MAXHOM alignment

Identities computed with respect to: (1) predict_h2270
Colored by: consensus/70% and property


                           1 [        .         .         .         .         :         .         .         .         .         1         .         .         .         .         :         .         .         .         .         2         .         .         .         .         :         .         .         .         .         3         .         .         .         .         :         .         .         .         .         4         .         .         .         .         :         .         .         .         .         5         .         .         .         .         :         .         .         .         .         6         .         .         .         .         :         .         .         .         .         7         .         .         .         .         :         .         .  ] 773
 1 predict_h2270  100.0%     MAEAHQAVAFQFTVTPDGIDLRLSHEALRQIYLSGLHSWKKKFIRFKNGIITGVYPASPSSWLIVVVGVMTTMYAKIDPSLGIIAKINRTLETANCMSSQTKNVVSGVLFGTGLWVALIVTMRYSLKVLLSYHGWMFTEHGKMSRATKIWMGMVKIFSGRKPMLYSFQTSLPRLPVPAVKDTVNRYLQSVRPLMKEEDFKRMTALAQDFAVGLGPRLQWYLKLKSWWATNYVSDWWEEYIYLRGRGPLMVNSNYYAMDLLYILPTHIQAARAGNAIHAILLYRRKLDREEIKPIRLLGSTIPLCSAQWERMFNTSRIPGEETDTIQHMRDSKHIVVYHRGRYFKVWLYHDGRLLKPREMEQQMQRILDNTSEPQPGEARLAALTAGDRVPWARCRQAYFGRGKNKQSLDAVEKAAFFVTLDETEEGYRSEDPDTSMDSYAKSLLHGRCYDRWFDKSFTFVVFKNGKMGLNAEHSWADAQIVAHLWEYVMSIDSLQLGYAEDGHCKGDINPNIPYPTRLQWDIPGECQEVIETSLNTANLLANDVDFHSFPFVAFGKGIIKKCRTSPDTFVQLALQLAHYKDMGKFCLTYEASMTRLFREGRTETVRSCTTESCDFVRAMVDPAQTVEQRLKLFKLASEKHQHMYRLAMTGSGIDRHLFCLYVVSKYLAVESPFLKEVLSEPWRLSTSQTPQQQVELFDLENNPEYVSSGGGFGPVADDGYGVSYILVGENLINFHISSKFSCPETDSHRFGRHLKEAMTDIITLFGLSSNSKK    
 2 cpt1_human     100.0%     MAEAHQAVAFQFTVTPDGIDLRLSHEALRQIYLSGLHSWKKKFIRFKNGIITGVYPASPSSWLIVVVGVMTTMYAKIDPSLGIIAKINRTLETANCMSSQTKNVVSGVLFGTGLWVALIVTMRYSLKVLLSYHGWMFTEHGKMSRATKIWMGMVKIFSGRKPMLYSFQTSLPRLPVPAVKDTVNRYLQSVRPLMKEEDFKRMTALAQDFAVGLGPRLQWYLKLKSWWATNYVSDWWEEYIYLRGRGPLMVNSNYYAMDLLYILPTHIQAARAGNAIHAILLYRRKLDREEIKPIRLLGSTIPLCSAQWERMFNTSRIPGEETDTIQHMRDSKHIVVYHRGRYFKVWLYHDGRLLKPREMEQQMQRILDNTSEPQPGEARLAALTAGDRVPWARCRQAYFGRGKNKQSLDAVEKAAFFVTLDETEEGYRSEDPDTSMDSYAKSLLHGRCYDRWFDKSFTFVVFKNGKMGLNAEHSWADAQIVAHLWEYVMSIDSLQLGYAEDGHCKGDINPNIPYPTRLQWDIPGECQEVIETSLNTANLLANDVDFHSFPFVAFGKGIIKKCRTSPDTFVQLALQLAHYKDMGKFCLTYEASMTRLFREGRTETVRSCTTESCDFVRAMVDPAQTVEQRLKLFKLASEKHQHMYRLAMTGSGIDRHLFCLYVVSKYLAVESPFLKEVLSEPWRLSTSQTPQQQVELFDLENNPEYVSSGGGFGPVADDGYGVSYILVGENLINFHISSKFSCPETDSHRFGRHLKEAMTDIITLFGLSSNSKK    
 3 cpt1_rat        86.4%     MAEAHQAVAFQFTVTPDGIDLRLSHEALKQICLSGLHSWKKKFIRFKNGIITGVFPANPSSWLIVVVGVISSMHAKVDPSLGMIAKISRTLDTTGRMSSQTKNIVSGVLFGTGLWVAVIMTMRYSLKVLLSYHGWMFAEHGKMSRSTKIWMAMVKVLSGRKPMLYSFQTSLPRLPVPAVKDTVSRYLESVRPLMKEEDFQRMTALAQDFAVNLGPKLQWYLKLKSWWATNYVSDWWEEYIYLRGRGPLMVNSNYYAMEMLYITPTHIQAARAGNTIHAILLYRRTLDREELKPIRLLGSTIPLCSAQWERLFNTSRIPGEETDTIQHIKDSRHIVVYHRGRYFKVWLYHDGRLLRPRELEQQMQQILDDPSEPQPGEAKLAALTAADRVPWAKCRQTYFARGKNKQSLDAVEKAAFFVTLDESEQGYREEDPEASIDSYAKSLLHGRCFDRWFDKSITFVVFKNSKIGINAEHSWADAPIVGHLWEYVMATDVFQLGYSEDGHCKGDTNPNIPKPTRLQWDIPGECQEVIDASLSSASLLANDVDLHSFPFDSFGKGLIKKCRTSPDAFIQLALQLAHYKDMGKFCLTYEASMTRLFREGRTETVRSCTMESCNFVQAMMDPKSTAEQRLKLFKIACEKHQHLYRLAMTGAGIDRHLFCLYVVSKYLAVDSPFLKEVLSEPWRLSTSQTPQQQVELFDFEKNPDYVSCGGGFGPVADDGYGVSYIIVGENFIHFHISSKFSSPETDSHRFGKHLRQAMMDIITLFGLTINSKK    
 4 cpt1_mouse      85.9%     ---------FQFTVTPDGIDLRLSHEALKQICLSGLHSWKKKFIRFKNGIITGVFPASPSSWLIVVVGVISSMHTKVDPSLGMIAKINRTLDTTGRMSSQTKNIVSGVLFGTGLWVAIIMTMRYSLKVLLSYHGWMFAEHGKMSRSTRIWMAMVKVFSGRKPMLYSFQTSLPRLPVPAVKDTVSRYLESVRPLMKEGDFQRMTALAQDFAVNLGPKLQWYLKLKSWWATNYVSDWWEEYIYLRGRGPIMVNSNYYAMEMLYITPTHIQAARAGNTIHAILLYRRTVDREELKPIRLLGSTIPLCSAQWERLFNTSRIPGEETDTIQHVKDSRHIVVYHRGRYFKVWLYHDGRLLRPRELEQQMQQILDDTSEPQPGEAKLAALTAADRVPWAKCRQTCFARGKNKQSLDAVEKAAFFVTLDESEQGYREEDPEASIDSYAKSLLHGRCFDRWFDKSITFVVFKNSKIGINAEHSWADAPIVGHLWEYVMATDVFQLGYSEDGHCKGDKNPNIPKPTRLQWDIPGECQEVIETSLSSASFLANDVDLHSFPFDTFGKGLIKKCRTSPDAFIQLALQLAHYKDMGKFCLTYEASMTRLFREGRTETVRSCTTESCNFVLAMMDPTTTAEQRLKLFKIACEKHQHLYRLAMTGAGIDRHLFCLYVVSKYLAVDSPFLKEVLSEPWRLSTSQTPQQQVELFDFEKYPDYVSCGGGFGPVADDGYGVSYIIVGENFTHFHISSKFSSPETDSHRFGKHLRQAMMAIITLFGLTANSKK    
 5 cptm_human      63.0%     MAEAHQAVAFQFTVTPDGVDFRLSREALKHVYLSGINSWKKRLIRIKNGILRGVYPGSPTSWLVVIMATVGSSFCNVDISLGLVSCIQRCLPQGCgqTPQTRALLSMAIFSTGVWVTGIFFFRQTLKLLLCYHGWMFEMHGKTSNLTRIWAMCIRLLSSRHPMLYSFQTSLPKLPVPRVSATIQRYLESVRPLLDDEEYYRMELLAKEFQDKTAPRLQKYLVLKSWWASNYVSDWWEEYIYLRGRSPLMVNSNYYVMDLVLIKNTDVQAARLGNIIHAMIMYRRKLDREEIKPVMALGI-VPMCSYQMERMFNTTRIPGKDTDVLQHLSDSRHVAVYHKGRFFKLWLYEGARLLKPQDLEMQFQRILDDPSPPQPGEEKLAALTAGGRVEWAQARQAFFSSGKNKAALEAIERAAFFVALDEESYSYDPED-EASLSLYGKALLHGNCYNRWFDKSFTLISFKNGQLGLNAEHAWADAPIIGHLWEFVLGTDSFHLGYTETGHCLGKPNPALAPPTRLQWDIPKQCQAVIESSYQVAKALADDVELYCFQFLPFGKGLIKKCRTSPDAFVQIALQLAHFRDRGKFCLTYEASMTRMFREGRTETVRSCTSESTAFVQAMMEGSHTKADLRDLFQKAAKKHQNMYRLAMTGAGIDRHLFCLYLVSKYLGVSSPFLAEVLSEPWRLSTSQIPQSQIRMFDPEQHPNHLGAGGGFGPVADDGYGVSYMIAGENTIFFHISSKFSSSETNAQRFGNHIRKALLDIADLFQV------    
 6 cptm_rat        62.9%     MAEAHQAVAFQFTVTPDGVDFRLSREALRHIYLSGINSWKKRLIRIKNGILRGVYPGSPTSWLVVVMATVGSNYCKVDISMGLVHCIQRCLPTRYggTPQTETLLSMVIFSTGVWATGIFLFRQTLKLLLSYHGWMFEMHSKTSHATKIWAICVRLLSSRRPMLYSFQTSLPKLPVPSVPATIHRYLDSVRPLLDDEAYFRMESLAKEFQDKIAPRLQKYLVLKSWWATNYVSDWWEEYVYLRGRSPIMVNSNYYAMDFVLIKNTSQQAARLGNTVHAMIMYRRKLDREEIKPVMALGM-VPMCSYQMERMFNTTRIPGKETDLLQHLSESRHVAVYHKGRFFKVWLYEGSCLLKPRDLEMQFQRILDDTSPPQPGEEKLAALTAGGRVEWAEARQKFFSSGKNKMSLDTIERAAFFVALDEDSHCY-NPDDEASLSLYGKSLLHGNCYNRWFDKSFTLISCKNGQLGLNTEHSWADAPIIGHLWEFVLATDTFHLGYTETGHCVGEPNTKLPPPQRMQWDIPEQCQTAIENSYQVAKALADDVELYCFQFLPFGKGLIKKCRTSPDAFVQIALQLAHFRDKGKFCLTYEASMTRMFREGRTETVRSCTSESTAFVRAMMTGSHKKQDLQDLFRKASEKHQNMYRLAMTGAGIDRHLFCLYIVSKYLGVRSPFLDEVLSEPWSLSTSQIPQFQICMFDPKQYPNHLGAGGGFGPVADHGYGVSYMIAGENTMFFHVSSKLSSSETNALRFGNHIRQALLDIADLFKIS-----    
 7 clat_mouse      31.3%     --------------------------------------------------------------------------------------------------------------------------------------------------------------------------LPKLPVPPLQQTLATYLQCMQHLVPEEQFRKSQAIVKRFGagLGETLQEKLLERQEKTANWVSEYWLNDMYLNNRLALPVNSSpvIFARQHFQDTNDQLRFAASLISGVLSYKALLDSQSIPTDWAKGQlqPLCMKQYYRLFSSYRLPGHTQDTLVamPEPEHVIVACCNQFFVLDVVINFRRLSEGDLFTQLRKIVKMASNEDERLPPIGLLTSDGRSEWAKARTVLLKDSTNRDSLDMIERCICLVCLDGPGTG------DLSDTHRALQLLHGGGcnRWYDKSLQFVVGRDGTCGVVCEHSPFDGIVLVQCTEHLLK----HMMTGNKKLVRVDSVSELPAPRRLRWKCSPETQGHLASSAEKLQRIVKNLDFIVYKFDNYGKTFIKKQKCSPDGFIQVALQLAYYRLYQRLVPTYESASIRRFQEGRVDNIRSATPEALAFVQAMTDHKAAvsEKLQLLQRAIQAQTEYTVMAITGMAIDNHLLALRELARDLCKEPPEMfyLMSNRFILSTSQVPT-TMEMFC------------CYGPVVPNGYGACYNPHAE-AITFCISSFHGCKETSSVEFAEAVGASLVDMRDL---------    
 8 clat_pig        31.0%     -----------------------------------------------------------------------------------------------------------------------------------------------------------------------EPGLPKLPVPPLQQTLATYLRCMQHLVPEEQFRRSQAIVQQFGagLGETLQQKLLERQEQTANWVSEYWLNDMYLNNRLALPVNSSpvIFARQHFQDTNDQLRFAANLISGVLSYKALLDSHSIPIDCAKGQlqPLCMKQYYGLFSSYRLPGHTQDTLVamPEPEHVIVACCNQFFVLDVVINFRRLSEGDLFTQLRKIVRMASNEDERLPPIGLLTSDGRSEWAEARTVLVKDSTNRDSLDMIERCICLVCLDAPGGM------ELSDTNRALQLLHGGGcnRWYDKSLQFVVGRDGTCGVVCEHSPFDGIVLVQCTEHLLK----HMVKSSKKMVRADSVSELPAPRRLRWKCSPEIQGLLASSAEKLQQIVKNLDFTVYKFDDYGKTFIKQQKCSPDAFIQVALQLAFYRLHGRLVPTYESASIRRFHEGRVDNIRSATPEALHFVKAITDHASAmsEKLLLLKDAIRAQTQYTVMAITGMAIDNHLLGLRELAREVCKELPEMFtlMSNRFVLSTSQVPT-TMEMFC------------CYGPVVPNGYGACYNPQPES-ILFCISSFHGCKETSSTKFAKAVEESFIEMKGLCSLSQS---    
 9 clat_rat        30.8%     -----------------------------------------------------------------------------------------------------------------------------------------------------------------------ELDLPKLPVPPLQQTLATYLQCMQHLVPEEQFRKSQAIVKRFGagLGETLQEKLLERQEKTANWVSEYWLNDMYLNNRLALPVNSSpvIFARQHFQDTNDQLRFAACLISGVLSYKTLLDSHSLPTDWAKGQlqPLCMKQYYRLFSSYRLPGHTQDTLVamPEPEHVIVACCNQFFVLDVVINFRRLSEGDLFTQLRKIVKMASNEDERLPPIGLLTSDGRSEWAKARTVLLKDSTNRDSLDMIERCICLVCLDGPGTG------ELSDTHRALQLLHGGGcnRWYDKSLQFVVGRDGTCGVVCEHSPFDGIVLVQCTEHLLK----HMMTSNKKLVRADSVSELPAPRRLRLKCSPETQGHLASSAEKLQRIVKNLDFIVYKFDNYGKTFIKKQKYSPDGFIQVALQLAYYRLYQRLVPTYESASIRRFQEGRVDNIRSATPEALAFVQAMTDHKAAmsEKLQLLQTAMQAHKQYTVMAITGMAIDNHLLALRELARDLCKEPPEMfyLMSNRFVLSTSQVPT-TMEMFC------------CYGPVVPNGNGACYNPQPE-AITFCISSFHSCKETSSVEFAEAVGASLVDMRDL---------    
10 cacp_human      30.0%     -----------------------------------------------------------------------------------------------------------------------------------------------ARTVVKPLGFLKPFSLMksRFKAHQDALPRLPVPPLQQSLDHYLKALQPIVSEEEWAHTKQLVDEFQagVGERLQKGLGRRARKTENWLSEWWLKTAYLQYRQPVVIYSSpvMLPKQDFVDLQGQLRFAAKLIEGVLDFKVMIDNETLPVEYLGGK--PLCMNQYYQILSSCRVPGPKQDTVSNfkPPTHITVVHNYQFFELDVYhdGTPLTADQIFVQLEKIWN--SSLQTNKEPVGILTSNHRNSWAKAYNTLIKDKVNRDSVRSIQKSIFTVCLDATMPR-VSEDVYRSH--VAGQMLHGGGsnRWFDKTLQFIVAEDGSCGLVYEHAAAEGFPIVTLLDYVIE-------YTKKPELVRSPMVPLPMPKKLRFNITPEIKSDIEKAKQNLSIMIQDLDITVMVFHHFGKDFPKSEKLSPDAFIQMALQLAYYRIYGQACATYESASLRMFHLGRTDTIRSASMDSLTFVKAMDDSSVTEHQKVELLRKAVQAHRGYTDRAIRGEAFGRHLLGLKLQAIEDLVSTPDIfyAIAMHFHLSTSQVPAKTDCVMF-------------FGPVVPDGYGVCYN-PMEAHINFSLSAYNSCAETNAARLAHYLEKALLDMRALLQSHPRAK-    
11 octc_rat        29.8%     --------------------------------------------------------------------------------------------------------------------------------------------------------------------FQYQDSLPPLPVPSLEESLKKYLESVKPFANEDEYKKTEEIVQKFQDGVGKTLHQKLLERAKGKRNWLEEWWLNVAYLDVRIPSQLNVNFvhFEHYWPAREGTQLERGSILLWHNLNYWQLLRREKL-PVHKSGN-TPLDMNQFRMLFSTCKVPGITRDSIMNyhCPTHIAVLCRGRAFVFDVLHDGCLITPPELLRQLTYIYQKCWN-EPVGPSIAALTSEERTRWAKAREYLIGlpENLTLLEKIQSSLFVYSIEDTSPHATPENFSQVFE----MLLGGDPAVRWGDKSYNLISFANGIFGCSCDHAPYDAMLMVNIAHYVDE----KLLETEGRWKGSEKVRDIPLPEELAFTVDEKILNDVYQAKAQHLKAASDLQIAASTFTSFGKKLTKKEALHPDTFIQLALQLAYYRLHGRPGCCYETAMTRYFYHGRTETVRSCTVEAVRWCQSMQDPSASLLERQQKMLDAFAKHNKMMRDCSHGKGFDRHLLGLLLIAKEEGLPVPELFegGGGNFVLSTSLVG--------------YLRIQGVVVPMVHNGYGFFYH-IRDDRFVVTCSSWRSCLETDAEKLVEMIFHAFHDMIHLMNTA-----    
12 cacp_colli      29.5%     ---------------------------------------------------------------------------------------------------------------------------------------MDRKQKQAEKARPYGLLKPAALGKIPGRFQLHQEALPHLPVPPLQQTLDRYLLALQPIISEEELNHTQELVAEFRkgVGERLQKGLERRAKKTDNWLSDWWLKTAYLEYRLPVVVHSSpvVLPKQDFQDRQGQLRFAAKLIEGILDFKTMIDNETLPVEYMGGK--PLCMNQYYQILSSCRIPGPKRDSIVNykQSRHITVVHNFQFFELDVYndGSPLTTDQLFIQLEKIWN--TSLQTNKEPVGILTTNHRNSWAKAYNNLLKDKTNKESVRTIEKSICTICLDAPMPR---VSDDIYKSPVAAQMLHGGGsnRWFDKTLQFIIAEDGSCGLVYEHAPAEGPPIVALLDHIVE-------YTKKPELVRSPMIPLPMPKKLRFNITPEIKSDIEKAKQNLNIMVEDLDVIVLVFHQFGKNYPKSEKISPDAFIQLALQLAYYRMYGHSCATYESASLRMFRLGRTDTIRSTSIESHKFVQSMDSPDKSDQEKADLLRRATQAHKEYTNMAIQGNAIDRHLLGLKLQAIEDLVSIPELfyAVAMHFNLSTSQVPAKTDCVMC-------------FGPVVPDGYGICYNPMGE-HINFAISAFNSCADTNAARMAHYLEKALLDMRSLLQSAPKSK-    
13 clat_human      27.5%     ----------------------------------GLRTAKkkWKREEGGGTRGRREVRPACFLQSGGRGDPGDVGGPAGNPGCSppAHTPAHTPEWCGAASAEAAEPRRAGPHLCIPAPG---------LTKTPILEKVPRKMAAKTP----------------SSEESGLPKLPVPPLQQTLATYLQCMRHLVSEEQFRKSQAIVQQFGagLGETLQQKLLERQEKTANWVSEYWLNDMYLNNRLALPVNSSpvIFARQHFPGTDDQLRFAASLISGVLSYKALLDSHSIPTDCAKPElqPLCMKQYYGLFSSYRLPGHTQDTLVamPEPEHVIVACCNQFFVLDVVINFRRLSEGDLFTQLRKIVKMASNEDERLPPIGLLTSDGRSEWAEARTVLVKDSTNRDSLDMIERCICLVCLDGPGGV------ELSDTHRALQLLHGGGynRWYDKSLQFVVGRDATCGVVCEHSPFDGIVLVQCTEHLLK----HMTQSSRKLIRADSVSELPAPRRLRWKCSPEIQGHLASSAEKLQRIVKNLDFIVYKFDNYGKTFIKKQKCSPDAFIQVALQLAFYRLHRRLVPTYESASIRRFQEGRVDNIRSATPEALAFVRAVTDHKAAvsEKLLLLKDAIRAQTAYTVMAITGMAIDNHLLALRELARAMCKELPEMfyLMSNRFVLSTSQVPT-TTEMFC------------CYGPVVPNGYGACYNPQPE-TILFCISSFHSCKETSSSKFAKAVEESLIDMRDLCSLLPPTE-    
14 cacp_mouse      28.3%     -----------------------------------------------------------------------------------------------------------------------------------------------ARTVVKPLGLLKPSSLMkgRFKAHQDALPRLPVPPLQQSLDYYLKALQPIVSEEEWAHTKQLVDEFQtgVGERLQKGLERRAKKMENWLSEWWLKTAYLqdKPVVIYSSPGVILPKQDFVDLQGQLRFAAKLIEGVLDFKSMIDNETLPVEFLGGQ--PLCMNQYYQILSSCREPGPKQDSVVNfrPPTHITVVHNYQFFELDVYndGTPLTSDQIFVQLEKIWN--SSLQSNKEPVGILTSNHRNTWAKAYNNLIKDKVNRESVNSIQKSIFTVCLDKQVPR---VSDDVYRNHVAGQMLHGGGsnRWFDKTLQFIVAEDGSCGMVYEHAAAEGPPIVALVDHVME-------YTKKPELVRSPMVPLPMPKKLRFNITPEIKNDIEKAKQNLSIMIQDLDIMMLTFHHFGKDFPKSEKLSPDAFIQVALQLAYYRIYGQACATYESASLRMFHLGRTDTIRSASIDSLAFVKGMGDSTVPEQQKVELLRKAVQAHRAYTDRAIRGEAFDRHLLGLKLQAIEDLVSMPDIfyAIAMHFNLSTSQVPAKTDCVMF-------------FGPVVPDGYGICYN-PMEAHINLSVSAYNSCAETNAARMAHYLEKALLDMRTLLQNHPRAK-    
15 octc_bovin      28.2%     ----------------------------------------------------------------------------------------------------------------------------------------------------------QLAKSTEERTFQYQDSLPSLPVPSLEESLKKYLESVKPFANEEEYKNTEAIVWKFQNGIGEKLQQKLLQRAKGRRNWLEEWWLNVAYLDVRIPSQLNVNfsHIEHYWPPKEGTQLERGSISLWHNLNYWQLLRKEKLAVEKVGNT--PLDMNQFRMLFSTCKIPGITRDSIINyhSPSHLAVLCRGRVFVFDVMHEGYLMTAPEIQRQLTYIQKKCH-SEPDGPGVAALTTEERTRWAKAREYLIsnPENLTILEKIQSSLLVFCLDDDSPHVTPED----YSQVSAKILNGDPTVRWGDKSYNLIAFSNGVFGSNCDHAPFDAMVLVKVCYYVDE----NILENEGRWKGSEKVRDIPVPEELVFTVDEKVLNDINQAKAQYFKQVSDLQLVVYAFTSFGKKLTKEKQLHPDTFIQLALQLAYYRLHGRPGCCYETAMTRLFYHGRTETVRPCTVEAVNWCQSMQNPSTSLLERKHMMLEAFAKHNKMMKDCSTGKGFDRHLLGLSLIAKEEGLPVPELfsGGGGNFVLSTSLVG--------------YLRVQGVMVPMVHNGYGFFYH-IRDDRFVVSCSAWKSCPETDAEKLVQQVFHAFCDMMQLMEM------    
16 cpt2_human      27.0%     -------------------------------------------------------------------------------------------------------------------------------LLRAWPRGPAVGPGAPSRPLSAGSGPGQYLQRSIVPTMHYQDSLPRLPIPKLEDTIRRYLSAQKPLLNDGQFRKTEQFCKSFENGIGKELHEQLvdKQNKHTSYISGPWFD-MYLSARDSVVLNFNPfaFNPDPKSEYNDQLTRATNMTVSAIRFLKTLRAGLLEPEVflVNAYPLDMSQYFRLFNSTRLPKPSRDELFTDDKARHLLVLRKGNFYIfvLDQDGNIVSPSEIQAHLKYILSDSS--PAPEFPLAYLTSENRDIWAELRQKLM-SSGNEESLRKVDSAVFCLCLDDFPIK--------DLVHLSHNMLHGDGTNRWFDKSFNLIIAKDGSTAVHFEHSWGDGVAVLRFFNEVFK-DSTQTP-AVTPQSQPATTDSTVTVQKLNFELTDALKTGITAAKEKFDATMKTLTIDCVQFQRGGKEFLKKQKLSPDAVAQLAFQMAFLRQYGQTVATYESCSTAAFKHGRTETIRPASVYTKRCSEAFVREPssAGELQQMMVECSKYHGQLTKEAAMGQGFDRHLFALRHLAAAKGIILPELyyGQINHNVLSTSTLSSPAVNL-------------GGFAPVVSDGFGVGYA-VHDNWIGCNVSS---YPGRNAREFLQCVEKALEDMfaLEGKSIKS--    
17 cacp_cantr      26.4%     ----------------------------------------------------------------------------------------------------------------------MFNFKLSQQVLKNSTKSIMPILKKPFSTSH-----------AKGDLFKYQSQLPKLPVPTLEETASKYLKTVEPFLNQEQLESTKAKVAEFVrgAGEALQARLNNFAADKDNWLAEFWDDYAYMSYRDPVVPYVSYfsHKDVKNIIGQDQLLKATLIAYYTIEFQEKVLDESLDPEVIKGN--PFCMNAFKYMFNNSRVPAEGSDITQHyeENQFFVVIYKNNFYKVPTHKNGQRLTKGEIYSYLQEIKNDAT---PKGLGLGALTSLNRDEWLSAYNNLLKSPINEASLGSIFASSFVIALDSNNPV--------TIEEKSKNCWHGDGQNRFFDKPLEFFVSANGNSGFLGEHSRMDATPTVQLNNTIYK-QILETNPNDLIVEIGSSAPRFGNAEILPFDINPTTRANIKDAIAKFDATIAAHDEEIFQHYGYGKGLIKKFKVSPDAYVQLLMQLAYFKYTGKIRPTYESAATRKFLKGRTETGRTVSNESKKFVETWSDPNASSADKVATFQAAAKQHVAYLSAAADGKGVDRHLFGLKQMIQPGEPIPEIFTdsYSQTWYISSSQVPSEFFQSW-------------GWSQVIDDGFGLAY-LINNDWIHVHISCK-RGNGLQSDHLKWYLvnEMKDVLTKGLLTDAKPK    
18 clat_caeel      27.0%     -----------------------------------------------------------------------------------------------------------------------------------------------------------------PNDNWYETALPKPPVPSLEATLDRYLeaVVAVGQKASLATTHDAAHKF-VRQATPLQEQLLEIAEKSPNWATKFWLPEMYMRVRMPTPVNSNPGYIFPKVKFETKEDHIKYTALLtgLLEYKNLIDTKQVCREKSTGAqlQMCMEQYDRVLSCYREPGVGEDTQIRKqgNEHVLVMCRNQTFLLHSRINGALVSYADVEYQLAQIEEISKINQNNTANIGASGVGPRDNAALFWQDMLTVEQNSKSYEWVKSALFVVCLDMEDPIDYGKNDTMSISEKEksTLTGHGsnRWYDATIQLVVSSSGVNGLCIEHSTAEGIVIINMAETAIRYAQKYFKSKMVWNDVRNV-----HPKSLTWHFSENSRNILKKQAEVFDELANELELEVLIFNEFGKDSIKNWRVSPDGFIQLIMQLAHYKTHGHLVSTYESASVRRFGAGRVDNIRANTQEALEWVTAMASKKESKERKLELFKKAVLKQVKVTLENISGYGVDNHLCALFCLARErdIPSLFLDPLWSerFPLSTSQVTT------SLDIPDCYLT----YGAVVRDGYGCPYNIQPDRVI-FAPTAFRSDPRTDLQHFKKSLAGAMRDVKELL--------    
19 cpt2_mouse      26.3%     ------------------------------------------------------------------------------------------------------------------------------RLLLRDWPRCPsvLGAPSRPLSAVSGPAEYLQHSIVPTMHYQDSLPRLPIPKLEDTMKRYLSAQKPLLNDSQFRKTEVLCKDFENGIGKELHAHLldKQNKHTSYISGPWFD-MYLTARDSVVLNFNPfaFNPDPKSEYNDQLTRATNLTVSAVRFLKTLRAGLLEPEVflVNAYPLDMSQYFRLFNSTRIPKPSRDELFTDTKARHLLVLRKGHFYVfvLDQDGNIVNPSEIQAHLKYILSDSS--PVPEFPLAYLTSENRDVWAELRQKLI-HGGNEETLRKVDSAVFCLCLDDF--------PMKDLVHLSHTMLHGDGTNRWFDKSFNLIVAKDGTAAVHFEHAWGDGVAVLRFFNEVFRDSTQTPAIAPQSQ--PAATDSSVSVQKLSFKLSSALKAGVTAAKEKFDATMKTLTIDAIQFQRGGKEFLKKKKLSPDAVAQLAFQMAFLRQYGQTVATYESCSTAAFKHGRTETICPASIFTKRCSEAFVREPssVGELQHMMAECSKYHGQLTKEAAMGQGFDRHLFALRYLAAARGVTLPELYqqRINHNILSTSTLSSPAVSL-------------GGFAPVVPDGFGIAYA-VHDDWIGCNVSS---YSGRNAREFLHCVQKCLEDMFDAL--------    
20 cpt2_rat        26.2%     -------------------------------------------------------------------------------------------------------------------------------LFRAWPRCPSLVLGAPSRPLSAVSGPDDYLQHSIVPTMHYQDSLPRLPIPKLEDTMKRYLNAQKPLLDDSQFRRTEALCKNFETGVGKELHAHLldKQNKHTSYISGPWFD-MYLTARDSIVLNFNPfaFNPDPKSEYNDQLTRATNLTVSAVRFLKTLQAGLLEPEVflVNAYPLDMSQYFRLFNSTRIPRPNRDELFTDTKARHLLVLRKGHFYVfvLDQDGNIVNPLEIQAHLKYILSDSS--PVPEFPVAYLTSENRDVWAELRQKLI-FDGNEETLKKVDSAVFCLCLDDF--------PMKDLIHLSHTMLHGDGTNRWFDKSFNLIVAEDGTAAVHFEHSWGDGVAVLRFFNEVFRDSTQTPAITPQSQ--PAATNSSASVETLSFNLSGALKAGITAAKEKFDTTVKTLSIDSIQFQRGGKEFLKKKQLSPDAVAQLAFQMAFLRQYGQTVATYESCSTAAFKHGRTETIRPASIFTKRCSEAFVRDPssVGELQHMMAECSKYHGQLTKEAAMGQGFDRHLYALRYLATARGLNLPELyyQQMNHNILSTSTLNSPAVSL-------------GGFAPVVPDGFGIAYA-VHDDWIGCNVSS---YSGRNAREFLHCVQKCLEDIFDAL--------    
21 cacm_yeast      26.1%     -------------------------------------------------------------------------------------------------------------------------------------------------------------------------NLKRLPIPPLQDTLNRYLARVETLQDERQNRRttVLSAENLDALNTLHERLLEYDARLasSYIEQFWYDAYLLyaTVVLNVNPYFQLQDDPTIKDTpvQVRRAARLTTSILKFIRQIRHGTLRTDTVRGK-TPLSMDQYERLFGSSRIPPGPGEPSCHLqtSHHVVAMYRGQFYWFDVLDTRnfATPEQLEWNLYSIIMDAESAGSGSAPFGVFTTESRRVWSNIRDYLFHAdtNWRNLKLIDSALFVVCLDDVAFAADQQDedPHQHQPPLNVQTGTCLNRWYDKL-QLIVTKNGKAGINFEHTGVDGHTVLRltDSILSFARGVTKNVVDIFSDDDGKplITIPRKLEWRTDNFLQSSLHFAETRISDLISQYEFVNLDFSNYGASHIKTvkCSPDAFVQQVFQVAYFALYGRFETVYEPAMTKAFQNGRTEAIRSVTGQSKLFVKSLLDQDASDATKIQLLHDACTAHSQITRECSQGLGQDRHLYALYCLWN------QWYKDKLELPPIFRDKSWTTMQNNVLSTSNCGNPCLKASGFGPVTANGFGIGYI-----IRDHSVSVVVSSRHRQTARFASLMEKSLLEIDRIFKRQQAR--    
22 cacp_yeast      25.0%     ---------------------------------------------------------------------------------------------------------------SNLKDLPITSRRAMHSAIVNYSTQKAQFPVETNNGEHYWAEKPNKFYQNkgITFAKQQDLPSLPVPELKSTLDKYLQTIRPFcdVETFERQQLLCKDFSEHMGPILQDRLKEYANDKRNWMAKFWDEQSYLQYNDPIVPYVSYfpLPNHLSKIDNDPLIKATAIISTVVKFIEAIKDESLPVEIIKG--MPFCMNSFSLMFNTSRLPGKPEDNQDTnyENNFVTIAYKGKFYKLMTHdnDKPLSENEIWRQLYSVVFQGSQSDPKLGGIGSLTSLPRDQWREVHLELMKDPISQDSLETIHKSSFMLCLDLDQSPVTLEEKSRNC-------WHGDGINRFYDKSLQFLVTGNGSSGFLAEHSKMDGTPTLFLNNYVCQQLNKLDVDDFMRKVITPSSTVAMKPMELPFIITPKIHKAIESAQLQFKETIGEHDLRVWHYNKYGKTFIKRHGMSPDAFIQQVIQLAVFKYLKRQLPTYEAASTRKYFKGRTETGRSVSTASLEFVSKWQNGDVPIAEKIQALKHSAKEHSTYLKNAANGNGVDRHFFGLKNMLKSNDDQIPPLFknYSSTWLISTSQLSS---EYFD----------GYGWSQVNDNGFGLAYMLNNE-WLHINIVNKPAKSGASVNRLHYYLSQAADEIFDALENENKRK-    
   consensus/100%            ..........................................................................................................................................................................L...PlP.l.tohthYL.t...h...tt..p.p.hs.p...t.s..hp..L...t....sahtt.W....hh..p.s.....................h.hhs..h...l.a...l.tt.l...h..s....hs..th..hhss.+.P...t-...t...spahhhhhp.pha.h....t...hp..ph...h..l.............hu..ss..R..h..hh..hh....s...ht.l.ts.hhhsl-.......................tGts.sRahDt..phh..tsu..u..h-Hs.h-u..hh.h...h.t........................s..h.h.hs....t.l..t...h...htthp.....a..hGtt..Kp.thpPDshhQ.hhQhAhht.htp...sYEss.htha..GRs-shpsso..sh.hs.th.p......ph..hh..s...p.thh..s..G.u.spHhhsL.............h.........hpsp.hs.....................hs.h..pG.Gh.Y.......h.ht.ss.....thp..chh..h.tth.th.th.........    
   consensus/90%             .......................................................................................................................................................................p.sLPpLPlP.lptohtpYLps.p.hh.ctphtp.p.hstpF..thu..Lp.hL..ht..ttsalpt.W.p.hYLp.+.sh.h..s.hhh........t.Qhhhhs.hh.thl.ahthlctt.l.s.hhhs...Phs.tQa..hhso.RlPt.tpD...t..tspHlhVhhp.pha.h.h..shp.lp..pl..pht.Ihp..p........luhLTsttRs.Wuphhp.hh....N.tslc.lppshhhlsLDt..................hthhpGts.sRWaDKohphlshtsu..uh.hEHu.h-u..hhthhp.lht........s.......t.....s.sppL.aphs.thpt.lttuht.hp.hhpphph.sh.F.thGKth.Kp.phSPDshhQhshQhAah+.htp.h.sYEss.hthF..GRs-slRsso..shthspuh.p...s.tph.thh..s.thptthh..s..G.uhDpHLhsLh...h........hh..h.....lSTSphst....................ausVs.sGaGhsY....-.hh.hphSs.....tpss.chhphl.tsh.-hhth.........    
   consensus/80%             .......................................................................................................................................................................ppsLP+LPVP.lppTlppYLpshpslhp-ppat+.ptlspcFtsslG.pLpthLh.+t.httNalucaW.p.hYLpsR.sl.lsss.hhh....h..hp.Qhthusthh.uhl.ahphlcpppl.s.hhhsp..Phs.tQa.thFso.RlPu.ppDpl.ph.pspHlhVhppspaahh.lh.stphlp.t-l..php.Ihp.so..tst...luhLTuttRs.WAchhp.hhtpstNppoLchlppuhhhlsLDt...h........s...huhphLHGts.sRWaDKohphllhpsGphGh.hEHu.hDu..lhphhphlhp........s.t...hss..s.hs.PpcLpaphs.phpt.lttuhpphphhhpslph.sh.F.taGKthhKpp+hSPDuFlQlAhQLAaa+.hGphs.TYEuu.hRhFtpGRs-slRsso.puhtaspuh.s.tts.tph.phhttA.ptHtphhh.AhpG.uhDpHLhsLh.hut..th..P.hh.hhut.ahLSTSphst...ph..............sauPVsssGaGhsY....-.hh.hplSuh.us.tpsutchhphltpuhhDhhslh........    
   consensus/70%                                               ...................................................................................................................................taQsuLP+LPVPsLppTlp+YLpshpPlhs--pap+pptlspcFtsulG.pLQthLh.+tthtsNalS-aW.p.hYLpsR.sl.lNss.hhhs..hh.tppsQhthAuphlpuhlpahphlcpcpl.s.hhhGp..PLCMpQa.plFsosRlPG.ppDsl.phppscHlhVhppspaFhl.lhpsuphls.t-l.hQLppIhp.sS..psst.sluhLTutsRs.WAcsRphhhtpstNcpSLctlcpuhFhlsLDtst.h......phshsphuhphLHGsshNRWaDKShphlVhcsGphGlshEHu.hDu.hllphhcalhp....phh.spph.hhssssstlshPp+Lpaplssphpsslppuhpphphhhpsl-hhsh.FppaGKshlKcp+hSPDuFlQlAlQLAaa+.hG+hssTYEuu.hRhFpcGRT-TlRSso.-uhtFVpuhhc.ssshtp+hphhpcAsptHpphhp.AhpGtuhDRHLhuLhhlup..shp.P.lh.hhup.ahLSTSQlsp.t.phh.............sauPVsssGaGhsY....-thI.hplSuh.usscTsut+hsphlppuhhDhhsLht......